IRCT2015021220993N2已完成未知
ow-Dose Intravenous Immunoglobulin decrease rate of Immunologic Abortion; a clinical trial
Vice chancellor of research in Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- Female
入选标准
- •inclusion criteria: women with at least two abortions that had taken place naturally or with assisted reproductive techniques (ART) and who had at least one positive immunologic test for anti-cardiolipin; anti-phospholipid antibodies;anti-thyroid antibody; anti-nuclear antibody;Anti-sperm antibody.
- •Exclusion criteria: anatomical problems; infections; hormonal factors contributing to recurrent abortion and parental factors were excluded.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of intravenous immunoglobulin on reduction of sepsis mortalityneonate infection.Bacterial sepsis of newborn, unspecifiedIRCT138710301378N4Mashhad university of medical sciences50
已完成
不适用
The high-dose intravenous immunoglobulin administration examination for high sensitization renal transplantation candidates.high sensitized renal transplantation candidatesJPRN-UMIN000012830Ehime University10
已完成
不适用
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30
尚未招募
不适用
Efficacy of intravenous immunoglobulin replacement therapy for hypogammaglobulinemia in severe infectionssevere infectious diseasesJPRN-UMIN000032802Sapporo Medical University300
尚未招募
Unknown
Intravenous Immunoglobulin replacement therapy for persistent COVID-19 in patients with B-cell impairment: a multicenter randomized controlled trialCertain infectious and parasitic diseasesKCT0009239Samsung Medical Center58